Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.
Pidala
Joseph
J
Department of Blood and Marrow Transplantation, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. joseph.pidala@moffitt.org
Kim
Jongphil
J
Anasetti
Claudio
C
Kharfan-Dabaja
Mohamed A
MA
Nishihori
Taiga
T
Field
Teresa
T
Perkins
Janelle
J
Perez
Lia
L
Fernandez
Hugo F
HF